Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies
Phase 1
Completed
- Conditions
- Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyeloproliferative DisordersAnemia, Refractory, With Excess of Blasts
- Interventions
- First Posted Date
- 2002-05-27
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT00038051
- Locations
- ๐บ๐ธ
UT MD Anderson Cancer Center, Houston, Texas, United States
A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
Phase 2
Completed
- Conditions
- Cutaneous T-cell LymphomaChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma
- Interventions
- Drug: Deoxycoformycin (DCF)
- First Posted Date
- 2002-05-27
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00038025
- Locations
- ๐บ๐ธ
M. D. Anderson Cancer Center, Houston, Texas, United States
Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening
Phase 3
Completed
- Conditions
- Adrenal Gland DiseasesAdrenal Gland Neoplasms
- First Posted Date
- 2002-05-24
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 114
- Registration Number
- NCT00037843
- Locations
- ๐บ๐ธ
University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
Phase 1
Completed
- Conditions
- Breast NeoplasmsMetastases, Neoplasm
- Interventions
- First Posted Date
- 2002-05-20
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT00037609
- Locations
- ๐บ๐ธ
University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Clofarabine in Chronic Lymphocytic Leukemia
Phase 1
Completed
- Conditions
- Hematologic NeoplasmsLymphoproliferative DisordersLeukemiaLeukemia, Lymphocytic, Chronic
- First Posted Date
- 2002-01-09
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT00028418
- Locations
- ๐บ๐ธ
University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath